Increased remnant lipoprotein in patients with coronary artery disease - Evaluation utilizing a newly developed remnant assay, remnant lipoproteins cholesterol homogeneous assay (RemL-C)

34Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Aim: Remnant lipoprotein is an emerging risk factor for coronary artery disease (CAD); however, the development of a specific remnant lipoprotein assay has struggled due to its heterogeneous nature. This study aimed to evaluate the clinical importance of a newly developed assay for remnant lipoprotein, RemL-C, in patients with CAD. Methods: This assay utilizes surfactant and phospholipase-D to selectively degrade and solubilize remnant lipoprotein. One hundred and sixty consecutive CAD patients who underwent coronary catheterization were recruited. Results: Remnant liporotein, RemL-C, was significantly higher in CAD patients (p < 0.001). Additionally, TG, hs-CRP, ICAM-1, VCAM-1, and homocysteine were significantly higher, but HDL-C and adiponectin were lower with LDL-C unchanged. Since RemL-C levels correlated with plasma TG levels, two subgroups, normotriglycedemic and normolipidemic CAD groups, were extracted. In both groups, RemL-C was still significantly higher than controls. HDL-C, but not RemL-C, was associated with the severity of CAD. RemL-C significantly correlated with TG-rich lipoproteins, in particular VLDL and IDL, when limited to normolipidemic CAD patients. Conclusion: Remnant lipoprotein, measured by RemL-C, was increased in CAD patients independent of TG levels, indicating impaired remnant lipoprotein metabolism in these patients. CAD severity was associated with HDL-C, but not with remnant lipoprotein, indicating differential roles of lipoproteins in the development of coronary atherosclerosis. This study therefore provides clinical significance to assess coronary risk by measuring RemL-C, particularly among patients with normal TG levels.

References Powered by Scopus

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

27800Citations
N/AReaders
Get full text

Inflammation and atherosclerosis

6398Citations
N/AReaders
Get full text

Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

6115Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Dietary fructose and glucose differentially affect lipid and glucose homeostasis

133Citations
N/AReaders
Get full text

Remnant lipoproteins as strong key particles to atherogenesis

118Citations
N/AReaders
Get full text

Postprandial hyperlipidemia and remnant lipoproteins

115Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Nakada, Y., Kurosawa, H., Tohyama, J. I., Inoue, Y., & Ikewaki, K. (2007). Increased remnant lipoprotein in patients with coronary artery disease - Evaluation utilizing a newly developed remnant assay, remnant lipoproteins cholesterol homogeneous assay (RemL-C). Journal of Atherosclerosis and Thrombosis, 14(2), 56–64. https://doi.org/10.5551/jat.14.56

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

43%

Professor / Associate Prof. 2

29%

Researcher 2

29%

Readers' Discipline

Tooltip

Medicine and Dentistry 5

56%

Biochemistry, Genetics and Molecular Bi... 2

22%

Sports and Recreations 1

11%

Chemistry 1

11%

Save time finding and organizing research with Mendeley

Sign up for free